What a complete balls up.
I hold KLL, but the KLL stockprice deserves everything thats coming for it. Management need to get whats coming to them also.
This was my fear all along, that the project would not deliver as promised in the DFS. My reason for concern was well justified I think, and I am glad I did not take up opportunities to top up along the way given the risks I had highlighted, which have now eventuated. It pays to be cautiously optimistic in investing. Never get emotionally attached to a stock, one must view it objectively, and one must be super critical of the risks by highlighting them more than the benefits.
A very very reluctant hold from me. I will not be adding anymore until I see cash flow so that I can assess the actual returns this project provides, and then assess if under or overvalued.
- Forums
- ASX - By Stock
- KLL
- Ann: BSOPP Feasibility Study Complete - New 120ktpa Base Case
Ann: BSOPP Feasibility Study Complete - New 120ktpa Base Case, page-65
-
- There are more pages in this discussion • 284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.28 |
Change
0.000(0.00%) |
Mkt cap ! $174.4K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KLL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online